E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/1/2006 in the Prospect News PIPE Daily.

New Issue: China Shenghou Pharmaceutical completes $1.8 million PIPE

By Sheri Kasprzak

New York, Sept. 1 - China Shenghou Pharmaceutical Holdings, Inc. settled a $1.8 million private placement of stock that closed concurrently with the company's share exchange with Lan's International Investment Co., Ltd.

The company sold 2 million shares in the deal.

WestPark Capital, Inc. was the placement agent for the offering.

Under the terms of the share exchange, China Shenghou agreed to issue 16,255,400 shares to Lan's International Medicine in exchange for 93.75% of the equity interest in subsidiary Kunming Shenghuo Pharmaceutical (Group) Co., Ltd.

Los Angeles-based China Shenghou develops nutritional supplements and cosmetic products.

Issuer:China Shenghou Pharmaceutical Holdings, Inc.
Issue:Stock
Amount:$1.8 million
Shares:2 million
Price:$0.90
Warrants:No
Placement agent:WestPark Capital, Inc.
Settlement date:Aug. 31

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.